Therapeutics for Memory and Cognition Disorders

Report Code: PHM054A

Publish Date: Apr 2009

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for therapeutics for memory and cognitive disorders will increase from $6.7 billion in 2008 to an estimated $7.3 billion by the end of 2009. It should reach almost $36.0 billion in 2014, a compound annual growth rate (CAGR) of 37.5%.
  • Treatments for Alzheimer’s disease have the largest share of the market, worth $3.9 billion in 2008. This is expected to increase to $4.4 billion in 2009 and $22.4 billion in 2014, for a CAGR of 38.8%.
  • Treatments for MCI/AACI have the second largest market share, generating $1.6 billion in 2008 and an estimated $1.7 billion in 2009. This should increase at a CAGR of 33.9% to reach $7.1 billion in 2014.

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
BCC’s goal in conducting this study is to determine the current status of the therapeutics and treatments for memory and cognition deficits and assess the growth potential of this area over a 5-year period from 2009 to 2014. We were particularly interested in how demographics are impacting the development efforts being undertaken currently and how memory/cognition is evolving into a therapeutic focus in its own right.
 
Our key objective is to present a comprehensive analysis of the current pipeline, the market and forecast for memory/cognition therapeutics and the key factors that will influence this therapeutic area in the next few years. 
 
REASONS FOR DOING THIS STUDY
 
As the mechanisms of the central nervous system become more elucidated, the opportunity for treating memory/cognition deficits and related diseases is coming to the forefront. This study aims to quantify where this market is heading and where the opportunities may lie.
 
SCOPE OF REPORT
 
Although there are several modes of treating memory and cognitive deficiency, the scope of this report is on the pharmaceutical segment. We have compiled a study of the market, and current and emerging modes of treatment. We present the market segment economic environment, technological descriptions and issues, applications, market factors and potential, and forecasts for 2009 to 2014. We also project usage in the major primary and secondary disease application areas. This study will be of interest to the drug industry, patients and the medical community. It will be of interest also to suppliers of products and services to this market area.
 
INTENDED AUDIENCE
 
The intended audience for this report is the pharmaceutical and biotechnology industries, as well as the medical industry which treats patients in these areas.
 
METHODOLOGY
 
Both primary and secondary research methods were used in preparing this study. BCC presents an analysis, by each disease area, of a number of current patients. Then, based on our surveys, we analyze the potential applications for pharmaceuticals, and forecast markets for 2009 and 2014. 
 
INFORMATION SOURCES
 
BCC surveyed approximately fifty companies to obtain data for this study. Included were drug development companies and medical professionals. We also spoke with patients affected by memory and cognition diseases.   In addition, we compiled data from current financial and trade information and government sources.
 
ANALYST CREDENTIALS
 
Maura Lane Warner has 16 years of industry experience, as both a chemical engineer and market and business development executive in the pharmaceutical and biotechnology industries. She has a BS in Chemical Engineering and an MBA in Marketing. Ms. Lane Warner has also authored a report on Microfluidics. 
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at
www.bccresearch.com enables readers to: 
  • Examine BCC’s complete catalog of market research reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Therapeutics for Memory and Cognition Disorders168Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY6Free
Chapter- 3: OVERVIEW10Free
Chapter- 4: APPLICATIONS49Free
Chapter- 5: MECHANISMS OF ACTION31Free
Chapter- 6: WORLDWIDE INDUSTRY STRUCTURE24Free
Chapter- 7: PATENT ANALYSIS19Free
Chapter- 8: OUTLOOK: TRENDS AND CHALLENGES4Free
Chapter- 9: C. CRAMER & CO. GMBH11Free
Chapter- 10: APPENDIX11Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 51

  • Summary Table: WORLDWIDE POTENTIAL MARKET FOR MEMORY/COGNITION THERAPEUTICS, BY DISEASE AREA, THROUGH 2014
  • Table 1: DIAGNOSTIC TESTS
  • Table 2: TOP COMPANIES WORKING IN MEMORY AND COGNITION AND ASSOCIATED WORLDWIDE MARKET SHARE
  • Table 3: DEMENTIA RATE BY UNDERLYING DISEASE STATE
  • Table 4: PERCENT OF PATIENTS WITH DEMENTIA/COGNITIVE DEFICIT
  • Table 5: WORLDWIDE DISEASE PREVALENCE: ALZHEIMER’S DISEASE
  • Table 6: EXISTING TREATMENTS: ALZHEIMER’S DISEASE
  • Table 7: TREATMENT FORECAST FOR ALZHEIMER’S DISEASE, THROUGH 2014
  • Table 8: WORLDWIDE DISEASE PREVALENCE: VASCULAR DEMENTIA
  • Table 9: EXISTING TREATMENTS: VASCULAR DEMENTIA
  • Table 10: TREATMENT FORECAST FOR VASCULAR DEMENTIA, THROUGH 2014
Sample Report

Recent Reports

Clinical Nutrition: Global Markets to 2031

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM198C

The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.

Substance Use Disorder Treatment: Global Markets to 2030

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM035D

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - PHM017H

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

Cardiovascular Drugs: Global Markets to 2030

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM191B

The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.

Emerging Drugs: Global Markets

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM291A

The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Therapeutics for Memory and Cognition Disorders
Customize Report
AI Sentiment